Emerging Triglyceride-Rich Lipoprotein Targeted Therapies: An Unmet Need in Cardiometabolic Disease

<b>Background/Objectives</b>: Hypertriglyceridemia (HTG) is a common multifactorial metabolic disorder often with genetic predisposition. Multiple lines of evidence support a causal role of triglyceride-rich lipoproteins (TRLs) in atherosclerotic cardiovascular disease (ASCVD), with severe HTG leadi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jorge Ferreira, Miguel Domingues, António Ferreira
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-08-01
coleção:	Pharmaceutics
Assuntos:	angiopoietin-like 3 apolipoprotein C-III atherosclerotic cardiovascular disease hypertriglyceridemia triglyceride-rich lipoprotein
Acesso em linha:	https://www.mdpi.com/1999-4923/17/9/1107
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!